The implantable-cardioverter defibrillator (ICD) lead is the most vulnerable component of the ICD system. Despite advanced engineering design, sophisticated manufacturing techniques, and extensive bench, pre-clinical, and clinical testing, lead failure (LF) remains the Achilles' heel of the ICD system. ICD LF has a broad range of adverse outcomes, ranging from intermittent inappropriate pacing to proarrhythmia leading to patient mortality. ICD LF is often considered in the context of design or construction defects, but is more appropriately considered in the context of the finite service life of a mechanical component placed in chemically stressful environment and subjected to continuous mechanical stresses. This clinical review summarizes LF mechanisms, assessment, and differential diagnosis of LF, including lead diagnostics, recent prominent lead recalls, and management of LF and functioning, but recalled leads. Despite recent advances in lead technology, physicians will likely continue to need to understand how to manage patients with transvenous ICD leads. (J Am Coll Cardiol 2016;67:1358-68)
Dual-coil leads may provide superior defibrillation for some right-sided implants, but they are associated with greater procedural extraction risk due to fibrotic tissue ingrowth into the proximal coil (2) .
ICD leads have 2 types of sensing designs, both using the tip electrode as a cathode. The dedicated bipolar lead has a ring electrode as an anode dedicated to sensing. By contrast, the integrated bipolar lead uses the RV defibrillation coil, integrated with the shock circuit, as the anode. Therefore, a dedicated bipolar lead requires 1 more conductor than an integrated bipolar (11, 12) . Furthermore, most Optim-coated leads lack Optim between the silicone and shock coil. Thus, inside-out abrasions under the shock coil may result in contact of a conducting cable with a shock coil (13) (14) (15) . Contact between the proximal coil and cable to the distal coil may short the high-voltage conductors, preventing shock delivery to the patient.
INCIDENCE OF LF
The incidence of LF is difficult to determine due to 
OVERSENSING IN THE DIAGNOSIS OF PACE-SENSE COMPONENT MALFUNCTION
Oversensing refers to sensing of signals other than the QRS complex (19, 20) . Oversensing that varies with each cardiac cycle (cyclical oversensing) indicates an intracardiac source. Characteristics of the oversensed
Implantable Cardiac Defibrillator Leads signals in pace-sense LF have been reported (18) (19) (20) and must be distinguished from other causes of oversensing (19) ( Table 1) . This diagram shows the differential diagnosis and a deductive approach to the determination of the most likely cause of lead failure.
ICD ¼ implantable cardioverter-defibrillator; LF ¼ lead failure. *Real time electrograms including pace-sense electrograms with muscle exercise and pocket manipulation, shock electrograms, differential electrograms, and pacing and sensing thresholds. 
IMPEDANCE AND IMPEDANCE TRENDS IN THE DIAGNOSIS OF LF
ICDs measure electrical resistance (impedance) periodically for both pace-sense and high-voltage conductors (17, 19 ). An abrupt 50% to 75% relative increase in pace-sense impedance is a highly specific 
MANAGEMENT OF PATIENTS WITH FUNCTIONING RECALLED LEADS
For a patient with a functioning recalled lead, management focuses around a comprehensive baseline assessment and prescribing an intensified monitoring plan. A baseline chest radiograph may identify An example of diagnostics from a patient with a Medtronic Sprint Quattro lead failure (LF) detected by the lead integrity alert (LIA). Upper panel:
Components of LIA are shown with thresholds for alert. In this case, the pace-sense impedance trend was normal. LIA was activated by the combination of rapid oversensing of nonphysiological short intervals cumulated in the sensing integrity count (SIC) and 2 episodes of rapid nonsustained tachycardia (NST). Chest x-ray showed that the DF4 pin was inserted completely into header and revealed no abnormalities of lead or The decision to replace a functioning, recalled ICD (either at pulse generator change or electively) should be on the basis of multiple factors summarized in Table 3 . There is no consensus on how to manage patients with externalized cables, but no electrical abnormalities. Once a decision is made to replace a lead, a further decision may be made regarding extraction or addition of a new ICD lead, also considering factors summarized in Table 3 . Decision analysis models provide analytical, data-driven recommendations for making these complex decisions, but the recommendations depend critically on assumptions about risk (24) . When a magnet is applied to an ICD, detection will be disabled (as long as the magnet remains applied). Unlike pacemakers, ICDs do not alter bradycardia pacing parameters with magnet application.
ACUTE MANAGEMENT OF PATIENTS WITH INAPPROPRIATE SHOCKS

MANAGEMENT OF PATIENTS WITH CONFIRMED LF
Acute management of patients presenting with inappropriate shocks in normal rhythm centers on prompt inactivation of ventricular tachycardia/VF Abbreviations as in Tables 1 and 2 . Long-term management of most patients with confirmed LF centers around the decision to extract or add a lead (Table 3) 
